Birinyi László, Kalamász Nikoletta Zsófia, Major Tamás, Borsos Antal, Bacskó György
Debreceni Egyetem, Orvos és Egészségtudományi Centrum Altalános Orvostudományi Kar, Szülészeti és Nógyógyászati Klinika.
Orv Hetil. 2002 Dec 8;143(49):2735-40.
The benign uterine fibroid is one of the most common cause for complains of females. The most important aim of the medicine nowadays is to treat the patient with minimally invasive methods, saving the organ.
Authors evaluate the efficacy of the transcervical hysteroscopic fibroid resection (TCRM) among their patients.
Authors performed 66 transcervical hysteroscopic fibroid resection (TCRM) in 61 patient in a six-year period. Based on clinical computed database and mailed questionnaires 51 patients were followed up.
30 out of 51 patients showed no symptoms after the procedure, in 14 cases subsequent fibroid was detected, while in 7 cases other type of complains occurred not related to the myoma. During the procedures complications appeared only in 4 cases, one perforation and three bleeding episodes occurred.
Based on the data authors emphasize that TCRM is a safe and excellent method in treating submucosal fibroids.
良性子宫肌瘤是女性主诉的最常见病因之一。当今医学的最重要目标是以微创方法治疗患者,保留器官。
作者评估经宫颈宫腔镜子宫肌瘤切除术(TCRM)在其患者中的疗效。
作者在六年期间对61例患者进行了66次经宫颈宫腔镜子宫肌瘤切除术(TCRM)。基于临床计算机数据库和邮寄问卷对51例患者进行了随访。
51例患者中有30例术后无症状,14例检测到后续肌瘤,7例出现与肌瘤无关的其他类型主诉。手术过程中仅4例出现并发症,发生1例穿孔和3次出血事件。
基于这些数据,作者强调TCRM是治疗黏膜下肌瘤的一种安全且出色的方法。